Scythian Biosciences Corp (SCYB.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 493 | 485 | 433 | 411 | 639 |
| Operating Expenses | 4,182 | 3,062 | 2,955 | 5,240 | 2,306 |
| Operating Income | -3,690 | -2,577 | -2,522 | -4,829 | -1,666 |
| Interest Expense | 234 | 38 | 204 | 4 | 54 |
| Other Income | -122 | -281 | -1,312 | 124 | 118 |
| Pre-tax Income | -4,046 | -2,896 | -4,038 | -4,709 | -1,602 |
| Net Income Continuous | -4,046 | -2,896 | -4,037 | -4,709 | -1,602 |
| Minority Interests | N/A | N/A | N/A | 1,882 | N/A |
| Net Income | $-4,046 | $-2,896 | $-10,325 | $-2,827 | $-1,602 |
| EPS Basic Total Ops | -0.20 | -0.10 | -0.41 | -0.11 | -0.10 |
| EPS Basic Continuous Ops | -0.20 | -0.10 | -0.41 | -0.11 | -0.10 |
| EPS Diluted Total Ops | -0.20 | -0.10 | -0.41 | -0.11 | -0.10 |
| EPS Diluted Continuous Ops | -0.20 | -0.10 | -0.41 | -0.11 | -0.10 |
| EBITDA(a) | $-3,415 | $-2,460 | $-3,467 | $-4,302 | $-1,165 |